CIDRAP newsletters options
Severe COVID-19 may bring more than twice the risk of dying within a year.
Delta-related COVID-19 activity showed signs of a plateau last week, the WHO says.
A study conducted in 15 hospitals found that discontinuing contact precautions for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) did not result in increased healthcare-associated infection (HAI) rates, researchers reported today in Infection Control & Hospital Epidemiology.
A third dose of the Pfizer/BioNTech mRNA COVID-19 vaccine appears to counteract waning vaccine protection in the short term, according to a preliminary case-control analysis of more than 500,000 coronavirus tests in Israel.
Those with compromised immune systems get COVID-19 after vaccination 3 times more often—but still rarely—a new study shows.
Merck's pill is on track to be the first approved treatment for COVID-19 infections.
Also, sequencing found hints that travelers with Omicron likely contracted the virus from different people in different locations.
Many COVID-19 survivors experience impaired circulation, abnormal breathing patterns, and chronic fatigue syndrome an average of 9 months after diagnosis, finds a small, single-center study yesterday in JACC: Heart Failure.
One study suggests the shots saved about 470,000 people 60 years and older in Europe.
Global officials are assessing how the variant will affect the arc of the pandemic.
Heads of vaccine firms say they can quickly retool existing vaccines to address the variant if needed.
A new report from the European Medicines Agency (EMA) shows sales of veterinary antimicrobials have fallen by more than 40% since 2011.
During a meeting tomorrow at the Radiological Society of North America (RSNA), scientists will present data from the largest multi-institutional international study to date on brain complications of COVID-19 and share that 1 in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system like stroke, hemorrhage, and other potentially fatal complications.
The US joins a growing list of nations that have banned flights from South Africa and related destinations.
Amid uncertainty about the meaning of the changes, intensive efforts are underway to gauge how the they might impact tests, treatments, and vaccine efficacy.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Nov 24
"While Europe is again the epicenter of the pandemic, no country or region is out of the woods."
The number of people flying in the US is double what it was for the same time last year.
The researchers call some types of emotional distress experienced by healthcare workers "moral injury."
SARS-CoV-2 antibody concentrations predict COVID-19 vaccine effectiveness, with higher levels correlating with greater protection, according to an ongoing US phase 3 clinical trial yesterday in Science.
